NRx is a clinical biopharma company focused on the high unmet need for lifesaving treatments for people with severe bipolar depression and PTSD in the presence of suicidality. Our website …

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression,...

We are NRx – an agile and specialized CNS biopharma company, resolutely focused on meeting very high unmet medical needs for those with severe bipolar depression with suicidality and post-traumatic stress disorder (PTSD).

Dec 30, 2024 · About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD.

Dec 30, 2024 · NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx", the "Company"), a clinical-stage biopharmaceutical company, today announced the transmission of first section of its New Drug Application (NDA)...

Jan 13, 2025 · NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically...

We focus on serious, life-threatening conditions with major unmet medical needs. Our growing pipeline is powered by our proprietary, dual-targeted mechanism of action, which safely modulates the NMDA and 5HT2A receptors.

4 days ago · Get a real-time NRx Pharmaceuticals, Inc. (NRXP) stock price quote with breaking news, financials, statistics, charts and more.

Dec 30, 2024 · NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia.

4 days ago · NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal …